Viser 51 - 68 av 68 resultater
Tid Selskap Tittel Sektor Kategori
04 Aug 2023
23:35 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. Extraordinary General Meeting to Confirm New Executive Director Appointments to the Board, Being Held on September 15, 2023 20103010 Biotechnology General meeting / Board Meeting
04 Aug 2023
23:30 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. Announces Proposed Appointment of Dr. Frank Weber as Chief Executive Officer 20103010 Biotechnology Other subject
16 Jul 2023
09:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. Shares Clinical Development Update Highlighting Progress of N3pE-Amyloid-targeting Small Molecule Varoglutamstat in Alzheimer’s Disease 20103010 Biotechnology Corporate life
21 Jun 2023
18:02 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. Reports Outcome of 2023 Annual General Meeting 20103010 Biotechnology General meeting / Board Meeting
15 Jun 2023
17:49 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. Announces CEO Transition Plan 20103010 Biotechnology Other subject
01 Jun 2023
07:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. to Participate in Upcoming Conferences 20103010 Biotechnology Meetings / events
26 May 2023
07:39 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics Successfully Completes Private Placement Raising EUR 25 Million 20103010 Biotechnology Change in Capital
25 May 2023
17:50 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics Launches Capital Increase by Way of an Accelerated Bookbuild Offering 20103010 Biotechnology Other financial transaction
16 May 2023
07:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. Reports Q1 2023 Financial Results and Highlights Operational Progress 20103010 Biotechnology Other subject
09 May 2023
07:02 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. to Hold its 2023 Annual General Meeting on June 21, 2023 20103010 Biotechnology General meeting / Board Meeting
09 May 2023
07:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. to Report Q1 2023 Financial Results and Operational Progress on May 16, 2023 20103010 Biotechnology Other subject
01 May 2023
10:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. Announces Planned Changes to Board Composition at 2023 Annual General Meeting 20103010 Biotechnology Other subject
24 Apr 2023
07:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. to Participate in Upcoming Conferences 20103010 Biotechnology Other subject
19 Apr 2023
07:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. Reports Full Year 2022 Financial Results and Highlights Operational Progress 20103010 Biotechnology Other subject
14 Apr 2023
07:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. to Report Full Year 2022 Financial Results and Operational Progress on April 19, 2023 20103010 Biotechnology Other subject
28 Mar 2023
07:00 CEST
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. Provides Progress Update on Varoglutamstat Clinical Development for the Treatment of Alzheimer's Disease 20103010 Biotechnology Other subject
21 Feb 2023
07:00 CET
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. to Present at Upcoming Conferences 20103010 Biotechnology Meetings / events
03 Feb 2023
14:32 CET
VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V. to Present at the 2023 BIO CEO & Investor Conference 20103010 Biotechnology Meetings / events